Peter Emtage
Directeur Général chez Santa Ana Bio, Inc.
Provenance du réseau au premier degré de Peter Emtage
Entité | Type d'entité | Industrie | |
---|---|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver.
34
| Holding Company | Investment Managers | 34 |
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. BiotechnologyHealth Technology Santa Ana Bio, Inc. is a biotechnology company that specializes in precision immunology for autoimmune diseases. The company is based in Alameda, CA. The CEO of the company is Peter Emtage.
4
| Holding Company | Biotechnology | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter Emtage via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
Versant Venture Capital VI (Canada) LP
Versant Venture Capital VI (Canada) LP Investment ManagersFinance Versant Venture Capital VI (Canada) LP operates as a pooled investment fund. The company is headquartered in San Francisco, CA. | Investment Managers | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Inception Sciences, Inc. provides small molecule pharmaceutical incubator services. Its focus is on creating therapies with transformative potential to address diseases and disorders. The company creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded in 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Inception IBD, Inc.
Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Ventus Therapeutics, Inc.
Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
Ventus Therapeutics U.S., Inc.
Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Medical Distributors | Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member | |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
University of Wisconsin | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Blueline Bioscience
Blueline Bioscience Investment ManagersFinance Blueline Bioscience acts as an alternative investment manager. The company is headquartered in Toronto, Canada. | Investment Managers | Director/Board Member Director/Board Member Director/Board Member | |
University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
CRISPR THERAPEUTICS AG | Biotechnology | Chairman Director/Board Member Chief Operating Officer | |
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member Founder Corporate Officer/Principal | |
CODA Biotherapeutics, Inc.
CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA. | Medical Specialties | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Jengu Therapeutics, Inc.
Jengu Therapeutics, Inc. BiotechnologyHealth Technology Jengu Therapeutics, Inc. is a biotechnology company. The company is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
Tentarix Biotherapeutics, Inc. | Chief Executive Officer Director/Board Member | ||
MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Vensana Capital Management LLC
Vensana Capital Management LLC Investment ManagersFinance Vensana Capital Management LLC (Vensana Capital) is a venture capital and growth equity investment firm founded in 2019 by Peter Klein Justin & Kirk G. Nielsen. The firm is headquartered in Saint Paul, Minnesota. | Investment Managers | Consultant / Advisor Founder | |
MORPHOSYS AG | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
CONTINEUM THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Chinook Therapeutics U.S., Inc.
Chinook Therapeutics U.S., Inc. Information Technology ServicesTechnology Services Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA. | Information Technology Services | Director/Board Member Director/Board Member | |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Founder | |
Antipodean Pharmaceuticals, Inc.
Antipodean Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Antipodean Pharmaceuticals, Inc. manufactures pharmaceutical products and provides pre clinical services. Its product MitoQ, which blocks mitochondrial oxidative damage and prevents cell death. The company was founded in 2002 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Golden Gate University | College/University | Graduate Degree Graduate Degree | |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman | |
Nested Therapeutics, Inc.
Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nested Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company focuses on discovering and developing novel, targeted, small molecule precision medicine therapies for cancer patients. The company uses mutation clusters to identify druggable pockets and have a platform that utilizes insights from genomics, computational chemistry, proteomics, and AI. Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations to reach a broader group of patients. The company was founded by Arvin Dar and Klaus Hoeflich. The CEO is Darrin Miles. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Northern Mosaic LP
Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Private Equity Investor | |
TURNSTONE BIOLOGICS CORP. | Biotechnology | Director/Board Member Chairman | |
CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Euro Ventures, Inc. | Chairman Founder | ||
Turnstone Biologics, Inc.
Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Chairman | |
Kyras Therapeutics, Inc.
Kyras Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kyras Therapeutics, Inc. operates as a biopharmaceutical company that develops drugs for incurable cancers and developmental disorders caused by RAS gene mutations. The company was founded by Brent R. Stockwell in 2015 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Chairman Director/Board Member | |
FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Jecure Therapeutics, Inc.
Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Monte Rosa Therapeutics AG
Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
University of Toronto | College/University | Doctorate Degree Doctorate Degree | |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novira Therapeutics LLC
Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 39 |
Canada | 8 |
Suisse | 5 |
Allemagne | 2 |
Sectorielle
Health Technology | 28 |
Commercial Services | 10 |
Consumer Services | 6 |
Finance | 4 |
Health Services | 3 |
Opérationnelle
Director/Board Member | 164 |
Corporate Officer/Principal | 63 |
Private Equity Investor | 41 |
Chairman | 27 |
Chief Executive Officer | 25 |
Relations les plus connectées
Insiders | |
---|---|
Bradley Bolzon | 41 |
Thomas Woiwode | 39 |
Jerel Davis | 29 |
Kirk Nielsen | 25 |
Jeremy S. Caldwell | 22 |
Carlo Rizzuto | 22 |
Paul Grayson | 21 |
Richard D. van Doren | 14 |
Clare Ozawa | 14 |
Gianni Gromo | 14 |
Max Eisenberg | 11 |
Markus Warmuth | 11 |
Shinichiro Fuse | 10 |
Richard Glynne | 9 |
Peppi Prasit | 8 |
- Bourse
- Insiders
- Peter Emtage
- Connexions Sociétés